查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1969858

2026-2034年全球近視和老花眼治療市場規模、佔有率、趨勢和成長分析報告

Global Myopia and Presbyopia Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計近視和老花眼治療市場規模將從 2025 年的 275.1 億美元成長到 2034 年的 611 億美元，2026 年至 2034 年的複合年成長率為 9.27%。

全球近視和老花眼治療市場正穩定成長，主要受各年齡層視力障礙患者人數不斷增加的推動。螢幕使用時間的增加、電子設備的普及以及生活方式的改變，都加劇了兒童和青少年近視的盛行率。同時，全球人口老化也推動了老花眼治療需求的成長。人口結構和生活方式因素的共同作用，持續推動全球市場的擴張。

關鍵成長要素包括矯正鏡片、雷射手術和處方眼藥水的技術進步。微創手術和個人化視力矯正方案的創新使更多患者能夠選擇這些治療方案。人們對早期眼科檢查和預防性眼部保健意識提升也促進了治療方案採用率的上升。此外，新興經濟體眼科診所和眼科醫療服務的可近性提高也為市場成長提供了支持。

展望未來，對先進隱形眼鏡、智慧眼鏡和新型藥物療法的持續研究有望推動市場發展。各公司正投資研發延緩兒童近視發展的長期解決方案。隨著遠距驗光和數位化眼科篩檢工具的普及，眼科服務的可近性將進一步提高。隨著眼部健康日益受到重視，預計未來幾年該市場將保持強勁且持續的成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球近視與老花眼治療市場：以近視治療類型分類

  • 市場分析、洞察與預測
  • 更正
  • 手術治療
  • 藥物

第5章：全球近視與老花眼治療市場：依老花眼治療方法類型分類

  • 市場分析、洞察與預測
  • 處方鏡片
  • 隱形眼鏡
  • 人工水晶體
  • 屈光矯正手術

第6章 全球近視與老花眼治療市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Ziemer Ophthalmic Systems AG
    • Nidek Co. Ltd
    • Johnson & Johnson Vision
    • Essilor Ltd
    • Zeiss International
    • Alcon Vision LLC
    • Bausch & Lomb Incorporated
    • Haag-Streit UK
    • Topcon Corporation
簡介目錄
Product Code: VMR112110492

The Myopia and Presbyopia Treatment Market size is expected to reach USD 61.10 Billion in 2034 from USD 27.51 Billion (2025) growing at a CAGR of 9.27% during 2026-2034.

The Global Myopia and Presbyopia Treatment Market is growing steadily due to the rising number of people experiencing vision problems across all age groups. Increasing screen time, digital device usage, and changing lifestyles are contributing to a higher prevalence of myopia among children and young adults. At the same time, the aging population worldwide is driving demand for presbyopia treatments. This combination of demographic and lifestyle factors is supporting consistent market expansion globally.

Key growth drivers include technological advancements in corrective lenses, laser surgeries, and pharmaceutical eye drops. Innovations in minimally invasive procedures and customized vision correction solutions are attracting more patients. Growing awareness about early eye testing and preventive eye care is also increasing treatment adoption. In addition, better access to ophthalmology clinics and eye care services in emerging economies is supporting market growth.

In the future, the market is expected to benefit from ongoing research in advanced contact lenses, smart glasses, and novel drug therapies. Companies are investing in long-term solutions that slow myopia progression in children. The expansion of tele-optometry and digital eye screening tools will further enhance accessibility. As eye health becomes a priority, the market is projected to witness strong and sustainable growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Myopia Treatment Type

  • Corrective
  • Surgical
  • Drugs

By Presbyopia Treatment Type

  • Prescription Lenses
  • Contact Lenses
  • Intraocular Lenses
  • Refractive Surgery

COMPANIES PROFILED

  • Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Johnson Johnson Vision, Essilor Ltd, Zeiss International, Alcon Vision LLC, Bausch Lomb Incorporated, HaagStreit UK, Topcon Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY MYOPIA TREATMENT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Myopia Treatment Type
  • 4.2. Corrective Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY PRESBYOPIA TREATMENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Presbyopia Treatment Type
  • 5.2. Prescription Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Contact Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Intraocular Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Refractive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Myopia Treatment Type
    • 6.2.2 By Presbyopia Treatment Type
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Myopia Treatment Type
    • 6.3.2 By Presbyopia Treatment Type
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Myopia Treatment Type
    • 6.4.2 By Presbyopia Treatment Type
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Myopia Treatment Type
    • 6.5.2 By Presbyopia Treatment Type
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Myopia Treatment Type
    • 6.6.2 By Presbyopia Treatment Type
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MYOPIA AND PRESBYOPIA TREATMENT INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Ziemer Ophthalmic Systems AG
    • 8.2.2 Nidek Co. Ltd
    • 8.2.3 Johnson & Johnson Vision
    • 8.2.4 Essilor Ltd
    • 8.2.5 Zeiss International
    • 8.2.6 Alcon Vision LLC
    • 8.2.7 Bausch & Lomb Incorporated
    • 8.2.8 Haag-Streit UK
    • 8.2.9 Topcon Corporation